Status:

RECRUITING

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Lead Sponsor:

Boston Medical Center

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

End Stage Renal Disease

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages th...

Eligibility Criteria

Inclusion

  • ESRD (end stage renal disease) patients at BMC (Boston Medical Center)
  • Receiving hemodialysis
  • Has a dialysis access malfunction
  • Undergoing a diagnostic fistulogram for the dialysis access malfunction

Exclusion

  • None

Key Trial Info

Start Date :

August 3 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04399941

Start Date

August 3 2021

End Date

September 1 2026

Last Update

December 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Boston Medical Center

Boston, Massachusetts, United States, 02118